Animal models for infectious diseases caused by parasites: Leishmaniasis

Drug Discovery Today: Disease Models

Volumn 1, Issue 1, 2004, Pages 81-86

  De Oliveira, Camila I ^a   Teixeira, Maria Jânia ^a   Gomes, Régis ^a   Barral, Aldina ^a,b,c   Brodskyn, Cláudia ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Institute of Investigation in Immunology   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CELL LINE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE MODEL; HUMAN; IMMUNOASSAY; LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR; LEISHMANIASIS; NONHUMAN; PARASITE; REVIEW; SKIN INFECTION; SKIN ULCER; TH1 CELL; TH2 CELL; VISCERAL LEISHMANIASIS;

EID: 23744464359     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2004.07.005     Document Type: Review

References (38)

1. Bittencourt, A. et al. (1995) Leishmaniasis. In Doerr W, S.G. (Ed.), pp. 597651, Springer
2. Sacks, D. and Noben-Trauth, N. (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2, 845-858
3. Gumy, A. et al. (2004) The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgrounds. Int. J. Parasitol. 34, 433-444
4. Bogdan, C. et al. (2000) Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12, 64-76
5. Childs, G.E. et al. (1984) Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana, and L. aethiopica. Ann. Trop. Med. Parasitol. 78, 25-34
6. DeKrey, G.K. et al. (1998) Analysis of the immune responses of mice to infection with Leishmania braziliensis. Infect. Immun. 66, 827-829
7. Rey, J.A. et al. (1990) Infectivity of the subspecies of the Leishmania braziliensis complex in vivo and in vitro. Am. J. Trop. Med. Hyg. 43, 89-103
8. Travi, B.L. et al. (1998) Behavior of Leishmania braziliensis s.l. in golden hamsters: evolution of the infection under different experimental conditions. J. Parasitol. 74, 1059-1062
9. Rojas, E. and Scorza, J.V. (1995) Leishmania braziliensis: isolation from lesions by inoculation of hamsters with and without addition of salivary gland lysate from Lutzomyia youngi. Rev. Saude Publica 21, 1-5
10. Osorio, Y. et al. (2003) The site of cutaneous infection influences the immunological response and clinical outcome of hamsters infected with Leishmania panamensis. Parasite Immunol. 25, 139-148
11. Martinez, J.E. et al. (1991) Mestastatic capability of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis in golden hamsters. J. Parasitol. 77, 762-768
12. Almeida, M.C. et al. (1996) Dissemination of Leishmania (Viannia) braziliensis. J. Comp. Path. 115, 311-316
13. Bretscher, P.A. et al. (1992) Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257, 539-542
14. Doherty, T.M. and Coffman, R.L. (1996) Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. Exp. Parasitol. 84, 124-135
15. Theodos, C.M. et al. (1991) Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice. Infect. Immun. 59, 1592-1598
16. Samuelson, J. et al. (1991) A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva. J. Exp. Med. 173, 49-54
17. Belkaid, Y. et al. (1998) Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J. Exp. Med. 188, 1941-1953
18. Kamhawi, S. et al. (2000) Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science 290, 1351-1354
19. Bezerra, H.S. and Teixeira, M.J. (2001) Effect of Lutzomyia whitmani (Diptera: Psychodidae) salivary gland lysates on Leishmania (Viannia) braziliensis infection in BALB/c mice. Mem. Inst. Oswaldo Cruz 96, 349-351
20. Norsworthy, N.B. et al. (2004) Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect. Immun. 72, 1240-1247
21. Barral, A. et al. (1983) Late metastatic Leishmaniasis in the mouse. A model for mucocutaneous disease. Am. J. Trop. Med. Hyg. 32, 277-285
22. Barbosa, A.A. Jr. et al. (1987) The pathology of experimental visceral leishmaniasis in resistant susceptible lines of inbred mice. Braz. J. Med. Biol. Res. 20, 63-72
23. Squires, K. et al. (1989) Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. J. Immunol. 143, 4244-4249
24. Stern, J. et al. (1998) Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. J. Immunol. 140, 3971-3977
25. Kaye, P. et al. (1991) Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146, 2763-2770
26. Wilson, M. et al. (1996) Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J. Immunol. 156, 2231-2239
27. Tumang, M. et al. (1994) Role and effect of TNF-alpha in experimental visceral leishmaniasis. J. Immunol. 153, 768-775
28. Murray, H.W. et al. (1992) Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J. Immunol. 148, 1858-1863
29. Rousseau, D. et al. (2001) Sustained parasite burden in the spleen of Leishmania infantum-infected BALB/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge. Eur. Cytokine Netw. 12, 340-347
30. Gifawesen, C. and Farrel, J. (1989) Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters. Infect. Immun. 57, 3091-3096
31. Bunn-Moreno, M. et al. (1985) Hypergammaglobulinemia in Leishmania donovani infected hamsters: possible association with a polyclonal activator of B cells and with suppression of T cell function. Clin. Exp. Immunol. 59, 434-437
32. Fruth, U. et al. (1993) Leishmania major interferes with antigen presentation by infected macrophages. J. Immunol. 150, 1857-1864
33. Rodrigues, V. et al. (1992) Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasites antigens. Parasite Immunol. 14, 49-58
34. Melby, P. et al. (2001) The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1 -like cytokine response. J. Immunol. 166, 1912-1920
35. Shankar, A.H. and Titus, R.G. (1993) Leishmania major-specific, CD4+, major histocompatibility complex class II-restricted T cells derived in vitro from lymphoid tissues of naive mice. J. Exp. Med. 178, 101-111
36. Soares, M.B. et al. (1997) An in vitro model for infection with Leishmania major that mimics the immune response in mice. Infect. Immun. 65, 2837-2845
37. Russo, D.M. et al. (1998) Naive human T cells develop into Th1 or Th0 effectors and exhibit cytotoxicity early after stimulation with Leishmania-infected macrophages. J. Infect. Dis. 177, 1345-1351
38. Pompeu, M.M. et al. (2001) Differences in gamma Interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers. Infect. Immun. 69, 7453-7460